Journal of International Oncology››2019,Vol. 46››Issue (4): 193-198.doi:10.3760/cma.j.issn.1673-422X.2019.04.001
Yang Xiao1, Li Si2, Peng Jin3, Wang Lin4, Wu Yilun4, Feng Ying2
Received:
2019-01-10Revised:
2019-02-19Online:
2019-04-08Published:
2019-05-29Contact:
Feng Ying, Email: yingfeng27@scu.edu.cn E-mail:yingfeng27@scu.edu.cnSupported by:
Science and Technology Planning Project of Sichuan Province of China (2019YFS0318); Health and Family Planning Commission of Sichuan Province of China (16PJ434)
Yang Xiao1, Li Si2, Peng Jin3, Wang Lin4, Wu Yilun4, Feng Ying2. Effect of plasma membrane-associated sialidase NEU3 activity on the proliferation and apoptosis of osteosarcoma MG-63 cells[J]. Journal of International Oncology, 2019, 46(4): 193-198.
[1] Miyagi T, Yamaguchi K. Mammalian sialidases: physiological and pathological roles in cellular functions[J]. Glycobiology, 2012, 22(7): 880-896. DOI: 10.1093/glycob/cws057. [2] Yamamoto K, Takahashi K, Shiozaki K, et al. Potentiation of epidermal growth factormediated oncogenic transformation by sialidase NEU3 leading to Src activation[J]. PLoS One, 2015, 10(3): e0120578. DOI: 10.1371/journal.pone.0120578. [3] Rodriguez-Walker M, Daniotti JL. Human sialidase Neu3 is S-acylated and behaves like an integral membrane protein[J]. Sci Rep, 2017, 7(1): 4167. DOI: 10.1038/s41598-017-04488-w. [4] Tringali C, Lupo B, Silvestri I, et al. The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling[J]. J Biol Chem, 2012, 287(51): 42835-42845. DOI: 10.1074/jbc.M112.407718. [5] Shiga K, Takahashi K, Sato I, et al. Upregulation of sialidase NEU3 in head and neck squamous cell carcinoma associated with lymph node metastasis[J]. Cancer Sci, 2015, 106(11): 1544-1553. DOI: 10.1111/cas.12810. [6] Shi Z, Zhou H, Pan B, et al. Exploring the key genes and pathways of osteosarcoma with pulmonary metastasis using a gene expression microarray[J]. Mol Med Rep, 2017, 16(5): 7423-7431. DOI: 10.3892/mmr.2017.7577. [7] PosthumaDeBoer J, Witlox MA, Kaspers GJ, et al. Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature[J]. Clin Exp Metastasis, 2011, 28(5): 493-503. DOI: 10.1007/s10585-011-9384-x. [8] 陈阳, 吴英良, 山形贞子, 等. 细胞质唾液酸酶(Neu2)通过Cdk2通路抑制FBJ-LL细胞生长[J]. 沈阳药科大学学报, 2010, (2): 147-151. [9] Sandhu R, Lal H, Kundu ZS, et al. Serum fluoride and sialic acid levels in osteosarcoma[J]. Biol Trace Elem Res, 2011, 144(1-3): 1-5. DOI: 10.1007/s12011-009-8382-1. [10] Harrison DJ, Geller DS, Gill JD, et al. Current and future therapeutic approaches for osteosarcoma[J]. Expert Rev Anticancer Ther, 2018, 18(1): 39-50. DOI: 10.1080/14737140.2018.1413939. [11] Hata K, Tochigi T, Sato I, et al. Increased sialidase activity in serum of cancer patients: identification of sialidase and inhibitor activities in human serum[J]. Cancer Sci, 2015, 106(4): 383-389. DOI: 10.1111/cas.12627. [12] Miyagi T, Takahashi K, Hata K, et al. Sialidase significance for cancer progression[J]. Glycoconj J, 2012, 29(8-9): 567-577. DOI: 10.1007/s10719-012-9394-1. [13] Lin H, Hao Y, Zhao Z, et al. Sirtuin 6 contributes to migration and invasion of osteosarcoma cells via the ERK1/2/MMP9 pathway[J]. FEBS Open Bio, 2017, 7(9): 1291-1301. DOI: 10.1002/2211-5463.12265. |
[1] | Wang Peixin, Zhao Jun, Xu Shihong, Jiang Zhaoyang, Wang Xiaoqiang, Yang Hongjuan.Progress of ferroptosis-related mechanisms in osteosarcoma[J]. Journal of International Oncology, 2024, 51(5): 308-311. |
[2] | Wang Zihao, Wang Yu, Yang Xin, He Yi, Mo Xingkui, Yuan Tao.Research progress on the molecular mechanism and related treatments of ferroptosis in osteosarcoma[J]. Journal of International Oncology, 2024, 51(4): 239-244. |
[3] | Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan.Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity, proliferation, and apoptosis of multiple myeloma cells[J]. Journal of International Oncology, 2024, 51(3): 129-136. |
[4] | Zhang Keping, Zhao Yongsheng, Yang Juan, Fu Maoyong.Chlorogenic acid induces mitochondrial dysfunction in lung cancer A549 cells by inhibiting the PI3K-Akt pathway[J]. Journal of International Oncology, 2024, 51(1): 21-28. |
[5] | Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells[J]. Journal of International Oncology, 2023, 50(9): 513-519. |
[6] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[7] | Wu Jiali, Zhang Jiahui, Zhang Ping, Xiao Xinyue, Li Rui, Zhang Hongyu.Mechanism of Bcl-2 BH4 selective inhibitor BDA-366 on NK/T cell lymphoma cells[J]. Journal of International Oncology, 2023, 50(7): 413-418. |
[8] | Yang Ya, Wang Huili, Liu Yan, Guo Jinfeng, Wang Chunxia, Lyu Min, Shan Changping.Effects of GCSH gene on proliferation and apoptosis of gastric cancer SNU-1 cells[J]. Journal of International Oncology, 2023, 50(5): 257-262. |
[9] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[10] | Zhu Yi, Chen Jian.Mechanism of hydrogen sulfide in tumorigenesis and development and its donor-mediated anti-tumor effects[J]. Journal of International Oncology, 2023, 50(12): 729-733. |
[11] | Ma Xiaoping, Chang Junli, Sun Xingyuan, Yang Yanping.Study progression on mechanism of long non-coding RNAs regulating drug resistance in osteosarcoma[J]. Journal of International Oncology, 2023, 50(1): 51-54. |
[12] | Lian Haiwei, Yang Shuorui, Liu Renzhong.Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway[J]. Journal of International Oncology, 2022, 49(6): 321-326. |
[13] | Yang Ya, Ning Xiaofei, Li Bingliang, Yao Hui, Shan Changping, Lyu Min.Study on the mechanism of procyanidin mediated anti gastric cancer SNU-1 cell line by inducing the production of reactive oxygen species[J]. Journal of International Oncology, 2022, 49(5): 257-262. |
[14] | Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198. |
[15] | Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua.Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells[J]. Journal of International Oncology, 2022, 49(2): 73-78. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||